Thermo Fisher Scientific Inc ($TMO) Stock Forecast: Up 2.2% Today

What is Thermo Fisher Scientific Inc?

Thermo Fisher Scientific Inc. (TMO) operates in the medical research and single-use bioprocessing products sectors, standing out as a prominent player. The company is currently showing strong performance in the market.

Why is Thermo Fisher Scientific Inc going up?

TMO stock is up 2.2% on Jan 2, 2026 16:26

• The global single-use bioprocessing products market is expected to witness substantial growth, with Thermo Fisher Scientific Inc. playing a significant role in the industry's advancement, contributing to the optimistic market trends.
• Noteworthy increases in stakes by Allspring Global Investments Holdings LLC and Ninety One UK Ltd in TMO reflect a growing confidence in the company's future, potentially influencing a rise in the stock's value.
• Despite recent significant insider sales, the company's impressive quarterly earnings report surpassing expectations, coupled with the initiation of a new stock buyback program and quarterly dividend declaration, have likely bolstered investor trust in TMO.
• The collective institutional interest and portfolio adjustments by different investment entities indicate a favorable outlook for TMO, aligning with the current bullish market movement.

TMO Price Chart

TMO Technical Analysis

TMO News

Single-Use Bioprocessing Products Market Set to Reach USD 36 Billion by 2031 | Top Companies are Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corp.

The global single-use bioprocessing products market was valued at USD 9.2 billion in 2022 and is projected to reach USD 36 billion by 2031, exhibiting an 18.6% CAGR. This growth is driven by the adoption of disposable systems in biopharmaceutical manufacturing, offering benefits like reduced contamination risk and increased flexibility. North America currently leads the market, while the Asia-Pacific region is the fastest-growing due to expanding manufacturing capacities and government funding.

https://www.openpr.com/news/4333973/single-use-bioprocessing-products-market-set-to-reach-usd-36

Thermo Fisher Scientific Inc. $TMO Shares Purchased by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC increased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 9.6% during the third quarter, holding 117,281 shares valued at $62.245 million. This move is part of broader institutional interest, with other major funds also adjusting their positions in the medical research company. Insiders, however, have recently sold a significant number of shares, totaling over $86 million in the last ninety days.

https://www.marketbeat.com/instant-alerts/filing-thermo-fisher-scientific-inc-tmo-shares-purchased-by-allspring-global-investments-holdings-llc-2026-01-02/

Bank Pictet & Cie Europe AG Sells 3,510 Shares of Thermo Fisher Scientific Inc. $TMO

Bank Pictet & Cie Europe AG has reduced its stake in Thermo Fisher Scientific Inc. by selling 3,510 shares, now holding 36,194 shares valued at $17.56 million. Other institutional investors have also adjusted their holdings, while insiders have sold a significant number of shares recently. Thermo Fisher Scientific reported strong quarterly earnings, beating estimates, and announced a new stock buyback program for $5.00 billion along with a quarterly dividend of $0.43.

https://www.marketbeat.com/instant-alerts/filing-bank-pictet-cie-europe-ag-sells-3510-shares-of-thermo-fisher-scientific-inc-tmo-2026-01-02/

Regency Capital Management Inc. DE Has $2.70 Million Stock Position in Thermo Fisher Scientific Inc. $TMO

Regency Capital Management Inc. DE recently decreased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 29.0%, now holding 5,558 shares valued at $2.696 million. This change comes as Thermo Fisher beat Q3 earnings estimates, announced a $5.0 billion share buyback program, and declared a $0.43 quarterly dividend. Various institutional investors have adjusted their positions, and insiders have been net sellers, offloading shares worth roughly $86.5 million in the last 90 days.

https://www.marketbeat.com/instant-alerts/filing-regency-capital-management-inc-de-has-270-million-stock-position-in-thermo-fisher-scientific-inc-tmo-2026-01-01/

Ninety One UK Ltd Purchases 29,806 Shares of Thermo Fisher Scientific Inc. $TMO

Ninety One UK Ltd increased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 3.7% in the third quarter, acquiring an additional 29,806 shares. Other institutional investors also adjusted their holdings, while company insiders sold a significant number of shares totaling over $86 million in the last ninety days. Analysts have a "Moderate Buy" rating for TMO with an average price target of $616.60.

https://www.marketbeat.com/instant-alerts/filing-ninety-one-uk-ltd-purchases-29806-shares-of-thermo-fisher-scientific-inc-tmo-2026-01-01/

Trending Today

Shiba Inu ($SHIB) Crypto Forecast: Up 5.5% Today

Dogecoin ($DOGE) Crypto Forecast: Up 5.1% Today

Thermo Fisher Scientific Inc Price History

01.07.2025 - TMO Stock was down 5.1%

• The decline in Thermo Fisher Scientific's stock today may be linked to the adoption of a bearish stance by influential investors, as reflected in options trading activities.
• While TMO has consistently outperformed the market in the long run, short-term market sentiment and investor behavior can impact daily fluctuations.
• Investors might be capitalizing on gains or adjusting their positions in response to prevailing market conditions or internal company developments, influencing the stock's downward trajectory today.
• It is crucial for investors to assess both TMO's long-term growth prospects and the short-term market dynamics to make well-informed investment choices.

24.03.2025 - TMO Stock was down 7.2%

• Surpassing Q1 expectations, Thermo Fisher adjusted its full-year forecast downward due to tariffs and rising expenses, leading to a decline in stock value.
• Despite a strong Q1, concerns from investors emerged regarding the impact of U.S.-China tariffs on revenue and operating income, resulting in a stock decline.
• Over the last 15 years, Thermo Fisher Scientific has consistently outperformed in the market, demonstrating resilience, but current challenges like tariffs and cost pressures are affecting short-term performance.

30.08.2025 - TMO Stock was up 3.8%

• The positive market response to TMO's bond offering suggests investor confidence in the company's financial stability.
• The continued bullish interest from financial institutions and traders signals strong belief in Thermo Fisher Scientific's growth potential.
• Overall, TMO's bullish performance today could be linked to the successful bond offering and positive market sentiment.

02.00.2026 - TMO Stock was up 2.2%

• The global single-use bioprocessing products market is expected to witness substantial growth, with Thermo Fisher Scientific Inc. playing a significant role in the industry's advancement, contributing to the optimistic market trends.
• Noteworthy increases in stakes by Allspring Global Investments Holdings LLC and Ninety One UK Ltd in TMO reflect a growing confidence in the company's future, potentially influencing a rise in the stock's value.
• Despite recent significant insider sales, the company's impressive quarterly earnings report surpassing expectations, coupled with the initiation of a new stock buyback program and quarterly dividend declaration, have likely bolstered investor trust in TMO.
• The collective institutional interest and portfolio adjustments by different investment entities indicate a favorable outlook for TMO, aligning with the current bullish market movement.

18.11.2025 - TMO Stock was down 2.4%

• The decline in TMO stock may be linked to profit-taking by institutional investors actively trading the stock.
• Despite positive updates on strong quarterly earnings and a $5 billion share buyback program, concerns arose among investors due to insider selling by the CEO and COO, potentially contributing to the stock's downward trend.
• Weak performance by West Pharmaceutical Services (WST) in the healthcare sector could have also impacted investor sentiment towards TMO, as some may have shifted away from underperforming healthcare stocks.
• In sum, today's bearish movement in TMO stock seems influenced by profit-taking, insider selling concerns, and broader sector trends affecting investor outlook.

23.06.2025 - TMO Stock was up 11.9%

• Financial giants and deep-pocketed investors have shown a bullish sentiment towards Thermo Fisher Scientific, with a majority of traders leaning towards a positive outlook on the stock.
• The upcoming second-quarter earnings report, especially focusing on the Analytical Instruments segment, has generated optimism and interest among investors.
• The increased bullish options trading activity suggests that market players are anticipating positive growth and performance from Thermo Fisher Scientific in the near future.

23.06.2025 - TMO Stock was up 12.4%

• Q2 earnings and revenues of Thermo Fisher Scientific exceeded expectations, propelled by successful product launches and robust segment growth, resulting in a notable increase in the stock price.
• Notable bullish sentiment was observed in the options trends for TMO, with a majority of traders expressing optimism about the stock.
• Investors are placing emphasis on the growth prospects of Thermo Fisher's Analytical Instruments segment, foreseeing its positive impact on performance in the upcoming quarters.
• The optimistic outlook from major investors towards TMO, reflected through options activity, likely played a role in the stock's favorable market trajectory today.

22.06.2025 - TMO Stock was up 5.5%

• Thermo Fisher Scientific is set to report its Q2 earnings, with a focus on its Analytical Instruments segment, indicating potential positive performance in this area.
• The bullish approach adopted by deep-pocketed investors towards TMO, as reflected in the options market, could be driving the upward momentum in the stock price.
• The market seems optimistic about Thermo Fisher's growth prospects, especially with new technological launches in key segments, fueling investor confidence and contributing to the bullish movement in the stock today.

10.06.2025 - TMO Stock was up 4.6%

• Despite negative moves by financial institutions and stock downgrades by analysts, Thermo Fisher Scientific (TMO) saw a significant rise in stock price.
• Unusual options trading, displaying a mix of bullish and bearish trends, likely contributed to the stock's fluctuating price.
• Divergent opinions among traders and analysts may have caused market uncertainty, prompting increased buying activity and driving up the stock price.
• Investors possibly prioritized the company's strong fundamentals and future growth potential, overshadowing short-term bearish signals from analysts and options trades.

14.04.2025 - TMO Stock was down 5.0%

• The bearish movement in Thermo Fisher Scientific's stock today may be linked to Senator Markwayne Mullin's substantial sale of up to $700K worth of TMO shares, causing concerns among investors about the company's future prospects.
• Investors could be responding to the news of the Senator's sale by selling off their Thermo Fisher Scientific positions, putting downward pressure on the stock price.
• Despite the current bearish movement, Thermo Fisher Scientific's strong long-term fundamentals could offer a chance for investors to benefit from the stock price decline.

10.05.2025 - TMO Stock was up 3.3%

• The recent increase in TMO's stock price may be linked to the following factors:
• Investors' positive response to the 1.27% rise in TMO's price during the current market session, despite the recent downward trend.
• Possible renewed market optimism regarding TMO's future growth opportunities or potential positive developments within the company.
• The overall favorable market or sector sentiment may have buoyed TMO and other stocks, contributing to today's bullish movement.

01.09.2025 - TMO Stock was up 9.2%

• The stock of Thermo Fisher Scientific showed a strong upward trend today, likely influenced by a noteworthy Power Inflow alert, reflecting optimistic sentiment from institutional and retail investors.
• The company's decision to initiate a four-part bond offering in anticipation of a potential government shutdown might have also played a part in the positive trend, demonstrating proactive financial preparation and stability.
• The optimistic actions of financial institutions and the prevailing bullish sentiment among traders regarding TMO all contributed to the favorable momentum, underscoring confidence in the company's future prospects.